NovaBay Pharmaceuticals, Inc. Earnings Yield

Earnings Yield of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Earnings Yield growth rates and interactive chart.


Highlights and Quick Summary

Current Earnings Yield of NovaBay Pharmaceuticals, Inc. is -39.47% (as of December 31, 2021)
  • Earnings Yield for the quarter ending June 30, 2022 was -44.0% (a 19.99% increase compared to previous quarter)
  • Year-over-year quarterly Earnings Yield increased by 65.66%
  • Annual Earnings Yield for 2021 was -39.47% (a -16.27% decrease from previous year)
  • Annual Earnings Yield for 2020 was -47.14% (a -46.13% decrease from previous year)
  • Annual Earnings Yield for 2019 was -87.5% (a 77.3% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Earnings Yield of NovaBay Pharmaceuticals, Inc.

Most recent Earnings Yieldof NBY including historical data for past 10 years.

Interactive Chart of Earnings Yield of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Earnings Yield for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -44.0% -36.67%
2021 -39.47% -26.56% -29.85% -34.07% -39.47%
2020 -47.14% -57.53% -30.43% -56.67% -47.14%
2019 -87.5% -81.97% -33.53% -46.09% -87.5%
2018 -49.35% -15.2% -13.2% -10.0% -49.35%
2017 -11.71% -14.13% -21.3% -28.01% -11.71%
2016 -63.27% -78.05% -184.4% -285.71% -63.27%
2015 -347.03% -110.34% -53.23% -46.38% -347.03%
2014 -49.21% -14.29% -17.72% -16.24% -49.21%
2013 -17.89% -23.26% -23.08% -17.65% -17.89%
2012 -22.12% -23.66% -26.27% -16.15% -22.12%
2011 -15.04% -5.75% -15.04%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology